Radiosurgical management of brain metastases

Neurosurgery Clinics of North America

Volumn 22, Issue 1, 2011, Pages 45-51

  D'Ambrosio, Anthony L ^a,b,c   DeYoung, Chad ^b   Isaacson, Steven R ^a  

^a The Neurological Institute ^*  (United States)

^b VALLEY HOSPITAL   (United States)

^c ST JOSEPH S REGIONAL MEDICAL CENTER   (United States)

Author keywords

Brain; Management; Metastases; Metastasis; Radiation; Radiosurgery

Indexed keywords

AGE; BRAIN METASTASIS; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COGNITIVE DEFECT; HUMAN; IONIZING RADIATION; LEARNING DISORDER; MEMORY DISORDER; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; REVIEW; SEIZURE; STEREOTACTIC RADIOSURGERY;

BRAIN; BRAIN NEOPLASMS; HUMANS; NEOPLASM METASTASIS; RADIOSURGERY;

EID: 78649436360     PISSN: 10423680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nec.2010.08.002     Document Type: Review

References (33)

1. Linskey M.E., Andrews D.W., Asher A.L., et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010, 96:45-68.
2. Verhey L.J., Chen C.C., Chapman P., et al. Single-fraction stereotactic radiosurgery for intracranial targets. Neurosurg Clin N Am 2006, 17:79-97. v.
3. Suh J.H. Stereotactic radiosurgery for the management of brain metastases. N Engl J Med 2010, 362:1119-1127.
4. Fuks Z., Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell 2005, 8:89-91.
5. Garcia-Barros M., Paris F., Cordon-Cardo C., et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003, 300:1155-1159.
6. Lee Y., Auh S.L., Wang Y., et al. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood 2009, 114:589-595.
7. Szeifert G.T., Massager N., DeVriendt D., et al. Observations of intracranial neoplasms treated with gamma knife radiosurgery. J Neurosurg 2002, 97:623-626.
8. Gaspar L.E., Mehta M.P., Patchell R.A., et al. The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010, 96:17-32.
9. Andrews D.W., Scott C.B., Sperduto P.W., et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363:1665-1672.
10. Kondziolka D., Patel A., Lunsford L.D., et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999, 45:427-434.
11. Sanghavi S.N., Miranpuri S.S., Chappell R., et al. Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 2001, 51:426-434.
12. Wang L.G., Guo Y., Zhang X., et al. Brain metastasis: experience of the Xi-Jing hospital. Stereotact Funct Neurosurg 2002, 78:70-83.
13. Aoyama H., Shirato H., Tago M., et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006, 295:2483-2491.
14. Li B., Yu J., Suntharalingam M., et al. Comparison of three treatment options for single brain metastasis from lung cancer. Int J Cancer 2000, 90:37-45.
15. Lee Y.K., Park N.H., Kim J.W., et al. Gamma-knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer. Gynecol Oncol 2008, 108:505-509.
16. Rades D., Pluemer A., Veninga T., et al. Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases. Cancer 2007, 110:2285-2292.
17. Bindal A.K., Bindal R.K., Hess K.R., et al. Surgery versus radiosurgery in the treatment of brain metastasis. J Neurosurg 1996, 84:748-754.
18. O'Neill B.P., Iturria N.J., Link M.J., et al. A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys 2003, 55:1169-1176.
19. Schoggl A., Kitz K., Reddy M., et al. Defining the role of stereotactic radiosurgery versus microsurgery in the treatment of single brain metastases. Acta Neurochir (Wien) 2000, 142:621-626.
20. Muacevic A., Wowra B., Siefert A., et al. Microsurgery plus whole brain irradiation versus gamma knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol 2008, 87:299-307.
21. Shinoura N., Yamada R., Okamoto K., et al. Local recurrence of metastatic brain tumor after stereotactic radiosurgery or surgery plus radiation. J Neurooncol 2002, 60:71-77.
22. Aoyama H., Tago M., Kato N., et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 2007, 68:1388-1395.
23. Chang E.L., Wefel J.S., Hess K.R., et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 2009, 10:1037-1044.
24. Williams B.J., Suki D., Fox B.D., et al. Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications. J Neurosurg 2009, 111:439-448.
25. Gaspar L., Scott C., Rotman M., et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37:745-751.
26. Gaspar L.E., Scott C., Murray K., et al. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 2000, 47:1001-1006.
27. Nieder C., Molls M. Validation of graded prognostic assessment index for patients with brain metastases: in regard to Sperduto et al. (Int J Radiat Oncol Biol Phys 2008;70:510-514). Int J Radiat Oncol Biol Phys 2008, 72:1619. [author reply: 1619].
28. Sperduto C.M., Watanabe Y., Mullan J., et al. A validation study of a new prognostic index for patients with brain metastases: the graded prognostic assessment. J Neurosurg 2008, 109(Suppl):87-89.
29. Sperduto P.W., Berkey B., Gaspar L.E., et al. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008, 70:510-514.
30. Karnofsky DA, Burchenal JH The clinical evaluation of chemotherapeutic agents in cancer. Evaluation of chemotherapeutic agents 1949, 196. Columbia University Press, New York (NY). C.M. MacLeod (Ed.).
31. Lorenzoni J., Devriendt D., Massager N., et al. Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys 2004, 60:218-224.
32. Weltman E., Salvajoli J.V., Brandt R.A., et al. Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys 2000, 46:1155-1161.
33. Shaw E., Kline R., Gillin M., et al. Radiation Therapy Oncology Group: radiosurgery quality assurance guidelines. Int J Radiat Oncol Biol Phys 1993, 27:1231-1239.